Korean J Nephrol.
2006 Sep;25(5):863-869.
A Case Report of Successful Treatment with Plasmapheresis and Intravenous Immunoglobulin in a Renal Transplant Recipient with Acute Humoral Rejection
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea. yonsukim@sun.ac.kr
- 2Department of Surgery, College of Medicine, Seoul National University, Seoul, Korea.
- 3Department of Lab Medicine, College of Medicine, Seoul National University, Seoul, Korea.
- 4Department of Pathology, College of Medicine, Seoul National University, Seoul, Korea.
Abstract
- Acute humoral rejection after renal transplantation is associated with a higher frequency of allograft dysfunction and graft loss. We report a case of acute humoral rejection which was treated successfully with plasmapheresis and intravenous immunoglobulin. A 31- year-old man developed azotemia after kidney transplantation. Kidney biopsy finding was compatible with antibody-mediated rejection, demonstrated by the infiltration of monocytes and neutrophils and the deposition of C4d on glomerulus and peritubular capillaries. We performed five plasmapheresis with concomitant treatment of intravenous immunoglobulin after each session. With aggressive treatment, there was improvement of oliguric acute renal failure, accompanied by decrease in the percentage of PRA and the titer of donor specific antibodies. Repeated kidney biopsy revealed persistent C4d staining on peritubular capillaries despite disappearance of donor specific antibodies. In conclusion, plasmapheresis and intravenous immunoglobulin are effective in treating acute humoral rejection.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Heart Transplant Rejection Treated with Plasmapheresis
- Effect of High Dose Intravenous Immunoglobulins on the Treatment of Antibody Mediated Humoral Rejection and BK Virus Infection in Renal Transplant Recipients
- Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
- Overcoming high pre-transplant isoagglutinin titers using high-dose intravenous immunoglobulin, salvage plasmapheresis, and booster rituximab without splenectomy in ABO-incompatible living donor liver transplantation: a case report
- Successful treatment of refractory hemolytic uremic syndrome with intravenous gamma-immunoglobulin therapy
